27.11.2023 • Newsinvestment

UK Government Unveils £29.5 Billion of Investment at Global Business Summit

On Monday, UK Prime Minister Rishi Sunak announced £29.5 billion ($36.8 billion) of private sector investment in Britain at a gathering of global executives intended to showcase Britain’s appeal to global investors.

Backing some of the fastest growing and most innovative sectors in the UK, the transformative investments have been secured for projects in tech, life sciences, infrastructure, housing and renewable energy – which could create thousands of new jobs and drive growth across the country.

Sunak hopes his efforts to attract foreign investors will help revive the ailing British economy.

The new wave of investments come after the Chancellor of the Exchequer, Jeremy Hunt, unveiled the biggest business tax cut in modern history at last week’s Autumn Statement with a permanent extension of capital allowances, £4.3 billion of business rates support and a £7 billion Growth Fund.

As outlined by Hunt last week, the government wants to offer certainty to business by committing more than £4.5 billion in targeted funding to back the long-term future of the UK’s world-leading manufacturing industries – automotive, aerospace, clean energy and life sciences. This includes support for batteries and industries undergoing fundamental changes to remain at the forefront of the global transition to net zero.

Sunak commented: “Attracting global investment is at the heart of my plan for growing the economy. With new funding pouring into key industries like clean energy, life sciences and advanced technology, inward investment is creating high-quality new jobs and driving growth right across the country.”

UK Government Unveils £29.5 Billion of Investment at Global Business Summit

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.